Factors associated with quality of life and functional disability among rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs for at least 6 months

Aim To determine characteristics of rheumatoid arthritis ( RA ) patients in Korea using disease‐modifying anti‐rheumatic drugs ( DMARD s) for at least 6 months, and to identify factors associated with poor health‐related outcomes. Method A total of 2000 RA patients aged > 20 years, treated with DMARD s for at least 6 months, and signed informed consent, were enrolled in this non‐interventional, multicenter, cross‐sectional observational study...